CDT Equity Inc. (CDT) vs VivoSim Labs, Inc. (VIVS)
A side-by-side comparison of CDT Equity Inc. and VivoSim Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDT
CDT Equity Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VIVS
VivoSim Labs, Inc.
$0.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CDT vs VIVS
growth of $100 · dividends reinvested · last 1yCDT -100.0% (-100.0%/yr)VIVS -86.8% (-86.8%/yr)VIVS compounded faster over this window
Log scale — wide-divergence pair
CDT VIVS
CDT vs VIVS: by the numbers
- •CDT is the larger company ($716854 vs $518606 market cap).
- •CDT is profitable (6.30% net margin) while VIVS runs a net loss (-11016.07%).
Metrics side by side
Valuation
| Metric | CDT | VIVS |
|---|---|---|
| P/S ratio | 0.00 | 4.63 |
| P/B ratio | 0.00 | N/A |
| EV / EBITDA | 4.13 | N/A |
Profitability
| Metric | CDT | VIVS |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -8567.94% |
| Net margin | 6.30% | -11016.07% |
| ROE | 6.58% | N/A |
| ROIC | 4.47% | -579.89% |
Frequently asked
- Is CDT or VIVS more profitable?
- CDT runs the higher net margin — CDT at 6.30% versus VIVS at -11016.07%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.